COVID-19 vaccines, if developed in India, need antibody response in at least 50% cases for approval Posted on September 22, 2020 by Administrator_India By Administrator_India Capital Sands According to the draft guidelines for the development of COVID-19 vaccines, a vaccine developed in India should prove that at least 50 percent of those administere... Read More
